Updated 06:11 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,883.00 +0.78% CL 84.99 -0.85% BTC 64,683.65 -0.95%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,883 +0.78% BTC $64,684 −0.95% VIX 22.91 +18.70% latest tape · as of 06:11 UTC
The Screen · Financials · Insurance - Property & Casualty

Bahrain Kuwait Insurance Company B.S.C.

BKIC.BH · BAHRAIN (BHB) · USD · Market cap $162M

Bahrain Kuwait Insurance Company B.S.C.

FAIL · Does not pass the screen
0.46 USD

Price as of 12 Nov 2026Daily close, not a live quoteLast reviewed 5 days ago

Screened 2026-11-12 · the tape above runs as of 06:11 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price0.46 USD at the 12 Nov 2026 close
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed12 Nov 2026 (5 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

FAIR-VALUE RANGE

Our fair-value range: range not available (screen dated 2026-11-12).

Current read
Markup ?
Screened · screened 2026-11-12
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price0.46 USD
Our investment reviews on this name
2026-11-04Read Markup0.46+0.0% to today ✓Distribution gives way to Markup after a 7% rise in 5 weeks
2026-10-02Read Distribution0.43+7.0% to today Markup gives way to Distribution
2026-08-23Read Markup0.42+9.3% to today ✓Markdown gives way to Markup
2026-07-02Read Markdown0.42+9.3% to today First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Bahrain Kuwait Insurance Company B.S.C. holds its Markup at $0.46. Elevated stress, defensive posture warranted, held for 11 days.

As held on the ledger · 2026-11-12
PhaseMarkup
Quantitative stateElevated stress, defensive posture warranted, held for 11 days
Price at the screen$0.46
ValuationN/A trailing · N/A forward price to earnings
Values screenFAIL
The Workings

Five Screens, Shown in Full

Does not pass. Business activity: conventional financial services (interest-based)

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Its core business involves an activity the values screen does not clear. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Bahrain Kuwait Insurance Company B.S.C. does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when BKIC.BH's ethical verdict changes

Today BKIC.BH does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

Where & How to Trade

BKIC.BH trades on BAHRAIN (BHB) (the company is based in Bahrain). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-15 Markup $0.46 +0.0% Entry 10

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a moderate risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 7%.

2026-11-04 Markup · changed $0.46 +9.5% Entry 9

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a moderate risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 7%.

2026-10-28 Distribution $0.42 +0.0% Entry 8

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 7%.

2026-10-14 Distribution $0.42 -2.3% Entry 7

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 7%.

2026-10-02 Distribution · changed $0.43 +2.1% Entry 6

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a moderate risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 7%.

2026-08-23 Markup · changed $0.42 +0.0% Entry 5

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a moderate risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 7%.

2026-07-23 Markdown $0.42 +0.0% Entry 4

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a moderate risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 7%.

2026-07-18 Markdown $0.42 +0.0% Entry 3

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a moderate risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Our forward projection puts the odds of a 10% gain over the next month near 7%.

2026-07-03 Markdown $0.42 +0.0% Entry 2

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Markdown $0.42 Entry 1

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in BKIC.BH's Space

Screened names in the same industry · explore each on its own page.

The Ledger's Promise

This entry now belongs to the ledger. Whatever BKIC.BH does next, these words stay.

Bahrain Kuwait Insurance Company B.S.C. · BKIC.BH · Markup · $0.46
Recorded 2026-11-12 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.